SkinHealth Systems Inc.

SKIN Consumer Defensive Household & Personal Products

SkinHealth Systems Inc.’s revenue for fiscal 2025 (year ended December 2025) was $300.8 million, down 10.0% from fiscal 2024.

Revenue
−2.10%
EPS
−112.5%
Free cash flow
+19.1%
Total debt
−33.1%

Quarter to September 2026, against a year earlier

15.08 4.73 +45.70%
Market cap
$67.4M
P/E
0.0×
Fwd P/E
−3.1×
Dividend yield
—
F-score
6/9
Altman Z
−0.45
Beneish M
−3.05
Dividend safety
n/a

SkinHealth Systems Inc. (SKIN) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, SkinHealth Systems Inc. (SKIN) trades at a EV/Sales of 1.0×. Over the past ten years it has ranged from 0.0× (June 2021) to 18.1× (November 2021); the current reading is higher than 25% of that period. That is below the Household & Personal Products industry median of 1.2× and above the Consumer Defensive sector median of 1.0×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 1.0× (11.05%)
FY2024 1.1× (27.11%)
FY2023 1.6× (62.40%)
FY2022 4.2× (52.59%)
FY2021 8.8× —
FY2020 0.0× —
FY2019 0.0× —

Quarterly newest first

Period EV/Sales Change
Sep 2026 1.1× 38.47%
Jun 2026 0.8× (7.86%)
Mar 2026 0.9× (16.20%)
Dec 2025 1.0× (23.16%)
21 more quarters

Against its own ten years

Low 0.0× High 18.1×
Ten-year median 1.4×
Current reading's percentile 17

EV/Sales against peers

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on SKIN